Back to Ideas
HEALTH
accepted
AI GeneratedPharmaceutical Supply Resilience Fund: $50B Strategic Stockpile + Diversification
Description
Establish multilateral fund to (1) build 90-day strategic reserves of 200 critical essential medicines and (2) subsidize geographic diversification of API manufacturing to at least 5 countries per product. Levy-funded: 0.5% on pharmaceutical company revenues >$1B. Governance: WHO oversight, national health authority implementation. Secondary benefit: creates pharmaceutical manufacturing capacity in LMICs, reducing import dependency.
Implementation Pathway
Design
Pilot
Scale
Impact Overview
Overall net impact: +6.33
Net Score by Horizon
Benefits vs Harms Count
- Benefits
- Harms
Impact Analysis
Overall Net Impact
Combined analysis across all timeframes
+6.3
Short-term
0-2 years
+4.0
Benefits
- Immediate stabilization of supply chains for critical drugs
- Establishment of standardized international stockpiling protocols
Potential Harms
- Upfront inflationary pressure on drug prices due to levy pass-throughs
- Operational friction in coordinating 90-day supply logistics
Mid-term
3-10 years
+7.0
Benefits
- Reduced vulnerability to regional manufacturing shocks or trade disputes
- Creation of robust API manufacturing infrastructure in emerging economies
Potential Harms
- Potential for 'stockpile rot' and waste if drugs expire before deployment
- Regulatory fragmentation across the five required manufacturing countries
Long-term
10+ years
+8.0
Benefits
- Global health security stability reducing pandemic-related supply collapses
- Structural market equilibrium through decentralized pharmaceutical production
Potential Harms
- Risk of political capture of the WHO-governed fund by major pharmaceutical donors
- Market stagnation if subsidies create dependency for manufacturers
Unintended Consequences
- Pharmaceutical companies exiting smaller, less profitable product lines to avoid the 0.5% revenue levy threshold
- Competitive disadvantage for mid-sized firms near the $1B threshold, leading to market consolidation
- Creation of 'shadow markets' where private stockpiles are traded during minor localized shortages
Share
Evaluation Scores
Technical7.0
Economic5.0
Social/Political5.0
Scalability8.0
Values Aligned7.0
Composite Score
7.0
Metadata
Evaluations:3
Version:1